prostate-cancer

Documents about prostate-cancer

• The testosterone replacement therapy for prostate cancer patients: Time to take the leap?#370627HAL (France)
• What Urine Measures Is Not What Tissue Encodes: Compartment-Specific miRNA Coordination in Prostate Cancer#377116bioRxiv / medRxiv
• Biobehavioral correlates of multidimensional fatigue in men with prostate cancer: A secondary data analysis.#433935NCBI PubMed Central
• Disability Status and Prostate Cancer Screening Among US Men Aged 55 to 69 Years.#450115NCBI PubMed Central
• Nanotechnology in Prostate Cancer: PSMA-Targeted Nanoplatforms, TME-Responsive Therapy, Immunomodulation, and Clinical Translation Challenges.#465069NCBI PubMed Central
• Synergistic Effects of d-Tocotrienol and Xanthorrhizol in Prostate Cancer Cells#492216ScholarWorks@GSU
• Genetic variation in RNASEL associated with prostate cancer risk and progression#643809Harvard DASH
• A Prospective Evaluation of Early Acupuncture for Immediate Continence Enhancement After Prostatectomy#800430ClinicalTrials.gov
• The Effect of Propofol Based Total Intravenous Anesthesia on Oxidative Stress and Nitric Oxide#804021ClinicalTrials.gov
• Targeted Microwave Focal Therapy#829733ClinicalTrials.gov
• A Phase II Study Evaluating the Efficacy of Enzalutamide and the Role of ARv7 in Metastatic Castration Resistant Prostate Cancer (mCRPC) Patients With Visceral Disease.#840944ClinicalTrials.gov
• A Phase 1 Study of Pegilodecakin (LY3500518) in Participants With Advanced Solid Tumors#18576ClinicalTrials.gov
• Tumor-associated M2 macrophages promote prostate cancer invasion through the M-CSF-PCLAF pathway#302047PLOS
• Improving ovarian cancer risk assessment using a machine learning model developed on data from the Prostate Lung Colorectal Ovarian Cancer Screening Trial.#421253NCBI PubMed Central
• Tissue-specific transfer learning improves functional variant and therapeutic target discoveries in breast and prostate cancer#158306PLOS
• Contemporary neighborhood redlining and racial mortgage lending bias and disparities in prostate cancer survival.#13832NCBI PubMed Central
• Integrative analysis of urinary microRNAs for prostate cancer detection: A proof-of-concept study.#30580NCBI PubMed Central
• Peptide-specific Vaccination in HLA-A*02 Positive Patients With Biochemical Recurrence After Radical Prostatectomy#146246ClinicalTrials.gov
• PCa-Mamba: Spatiotemporal state space models for prostate cancer detection in multi-parametric MRI.#174628NCBI PubMed Central
• Exploring Lived Experiences of Men Diagnosed With Prostate Cancer in Oman: A Qualitative Study.#193384NCBI PubMed Central
• Impaired vitamin D signaling reveals neutrophils as key drivers of prostate cancer dissemination.#193537NCBI PubMed Central
• A RIPK2 activity signature in prostate cancer: Modulation by RIPK2 inhibition and clinical association.#222921NCBI PubMed Central
• Requirement for written informed consent and selection bias in a chart-review prostate cancer study.#258298NCBI PubMed Central
• AI in Prostate Cancer Screening & Diagnosis: A Registry-Based Study of ClinicalTrials.gov Trials.#288682NCBI PubMed Central
• Active Surveillance in Prostate Cancer : Current and Potentially Emerging Biomarkers for Patient Selection Criteria#292984Repositorio USS
• Identification of plasma protein profiles associated with risk groups of prostate cancer patients.#301371Lund University Publications
• The impact of ethnicity on decisions and decision making in prostate cancer : an integrative review#336539The Learning Edge
• The role of extracellular vesicles-associated proteins markers in prostate cancer: a review.#354912NCBI PubMed Central
• Global prostate cancer risk associated with microplastic exposure: a statistical and machine learning analysis.#358237NCBI PubMed Central
• Development and validation of multidimensional nomograms for predicting prostate cancer risk: a retrospective study.#371436NCBI PubMed Central
• Per- and Polyfluoroalkyl Substances Exposure in New Jersey Prostate Cancer Survivors: A Pilot Biomonitoring Study#440263bioRxiv / medRxiv
• Financial toxicity and distress among prostate cancer patients in Lebanon: a cross-sectional study.#469050NCBI PubMed Central
• Specialist Referral for Cardiovascular Risk in Patients With Prostate Cancer: A Randomized Clinical Trial.#631110NCBI PubMed Central
• A Prospective Investigation of PTEN Loss and ERG Expression in Lethal Prostate Cancer#643811Harvard DASH
• Adherence Dynamics for Whole Food Interventions in African-American Men#845637ClinicalTrials.gov
• 42 U.S.C. § 247b-5 — Preventive health measures with respect to prostate cancer#595365US Code (LII)
• A Study of 177Lu-DTPA-SC16.56 in People With Neuroendocrine Carcinomas of the Lung and Prostate#843352ClinicalTrials.gov
• Assessing Financial Toxicity Using the PROFFIT Questionnaire in Patients Treated With Mini-invasive Approach for Urological Malignancies.#802870ClinicalTrials.gov
• Medtronic Hugo™ Robotic Assisted Surgery (RAS) System in Urologic Surgery (Expand URO)#806557ClinicalTrials.gov
• Neural Stem Cell Preserving Brain Radiation Therapy & Stereotactic Radiosurgery in Patients With 1-6 Brain Metastases#838471ClinicalTrials.gov
• Conventional Care Versus Radioablation (Stereotactic Body Radiotherapy) for Extracranial Oligometastases#841311ClinicalTrials.gov
• Study of NMS-03305293 in Pts with Selected Advanced/Metastatic Solid Tumors#840056ClinicalTrials.gov
• Cost-effectiveness of ferumoxtran-enhanced macrophage-specific-MRI and PSMA-PET/CT versus ePLND for nodal staging in primary prostate cancer: a decision analysis based on updated phase-3 trial data#374092Figshare
• Effects of STM 434 Alone or in Combination With Liposomal Doxorubicin in Patients With Ovarian Cancer or Other Advanced Solid Tumors#802430ClinicalTrials.gov
• Phase I Open Label Dose Escalation Study to Investigate the Safety & Pharmacokinetics of AZD5312 in Patients With Androgen Receptor Tumors#827956ClinicalTrials.gov
• Outsmarting Metastatic Prostate Cancer: Integration of Imaging, Liquid Biopsies and Biomarkers With Artificial Intelligence.#805NCBI PubMed Central
• Reduced store operated calcium entry contributes to autophagy mediated escape of prostate cancer to oxaliplatin treatment#129299HAL (France)
• A Phase 1b Dose Escalation Trial of PSK®/Placebo With Docetaxel to Treat Metastatic Castration-resistant Prostate Cancer#148736ClinicalTrials.gov
• Proteomic Profiling Reveals HECTD4-dependent Regulation of Protein Ubiquitination and Signaling Pathways in Prostate Cancer.#150053NCBI PubMed Central
• A unique transcriptomic landscape defines African-specific grade group 1 prostate cancer#156737Unpaywall